Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 71–71 | Cite as

Bufexamac/chlorhexidine/lidocaine

Allergic contact dermatitis and drug eruptions: 3 case reports
Case report
  • 5 Downloads

Reference

  1. Harris AG, et al. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?. Australasian Journal of Dermatology 60: 53-56, No. 1, Feb 2019. Available from: URL: http://doi.org/10.1111/ajd.12910 - AustraliaCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations